42ND ANNUAL MEETING OF THE OBESITY SOCIETY AT OBESITYWEEK, Texas, Amerika Birleşik Devletleri, 03 Kasım 2024, cilt.32, ss.179, (Özet Bildiri)
Kratom is derived from the leaves of Mitragyna speciosa, an evergreen tree indigenous to Southeast Asia. Kratom has been marketed for aspects of obesity management. Our goal was to exam- ine whether chronic oral dosing of a standardized alkaloid enriched- kratom extract (KE) prevented weight gain in high fat diet (HFD; 45% fat) fed mice. In addition, we examined whether acute human equiva- lent doses of KE and the major alkaloid, mitragynine (MTG), differen- tially influence cardiopulmonary measures in normal weight or obese male mice.
Kratom is derived from the leaves of Mitragyna speciosa,
an evergreen tree indigenous to Southeast Asia. Kratom has been
marketed for aspects of obesity management. Our goal was to exam-
ine whether chronic oral dosing of a standardized alkaloid enriched-
kratom extract (KE) prevented weight gain in high fat diet (HFD; 45%
fat) fed mice. In addition, we examined whether acute human equiva-
lent doses of KE and the major alkaloid, mitragynine (MTG), differen-
tially influence cardiopulmonary measures in normal weight or obese
male mice
Kratom is derived from the leaves of Mitragyna speciosa,
an evergreen tree indigenous to Southeast Asia. Kratom has been
marketed for aspects of obesity management. Our goal was to exam-
ine whether chronic oral dosing of a standardized alkaloid enriched-
kratom extract (KE) prevented weight gain in high fat diet (HFD; 45%
fat) fed mice. In addition, we examined whether acute human equiva-
lent doses of KE and the major alkaloid, mitragynine (MTG), differen-
tially influence cardiopulmonary measures in normal weight or obese
male mice
Kratom is derived from the leaves of Mitragyna speciosa,
an evergreen tree indigenous to Southeast Asia. Kratom has been
marketed for aspects of obesity management. Our goal was to exam-
ine whether chronic oral dosing of a standardized alkaloid enriched-
kratom extract (KE) prevented weight gain in high fat diet (HFD; 45%
fat) fed mice. In addition, we examined whether acute human equiva-
lent doses of KE and the major alkaloid, mitragynine (MTG), differen-
tially influence cardiopulmonary measures in normal weight or obese
male mice